Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Parathyroid Disease

  • You have access
    Utility of MIBI SPECT-CT and contrast-enhanced CT in primary hyperparathyroidism
    David Leung, Donna Eckstein, Katherine Lameka, James Lee and Chaitanya Divgi
    Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 476;
  • You have access
    The role of Tc-99m-MIBI SPECT/CT in localization diagnosis of parathyroid adenoma and hyperplasia
    Lian Xu, Xiaoguang Sun, Shaoli Song and Yuan Han
    Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 475;
  • You have access
    Management of cancer thyroid: Is there a role for carbimazole?
    Hussein Farghaly, Waleed Diab, Lamia Mahmoud, Hemat Mahmoud, Nahla Bashank and Asmaa Mohamed
    Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 480;
  • You have access
    Clinical impact of SPECT/CT in the surgical treatment of primary hyperparathyroidism
    Handan Tokmak and M. Onur Demirkol
    Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 479;
  • You have access
    Any additional value of quantitative assessment of dual-phase Tc-99m sestamibi parathyroid scan in patients with hyperparathyroidism
    Sasikorn Feinggumloon, Wichana Chamroonrat, Suchawadee Musikarat, Pichanun Pothisoonthorn, Chirawat Utamakul and Chanika Sritara
    Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 478;
  • You have access
    The value of parathyroid I-123/Tc-99m subtraction SPECT/CT in primary hyperparathyroidism
    Alex Korsten, Karen van Os, Jan Wille, Ingo Eland and Marie Monique van Buul
    Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 477;
  • You have access
    Comparison between SPECT/CT in Tc-99m MIBI parathyroid scintigraphy and ultrasonography for preoperative localization in hyperparathyroidism
    Atsushi Yoshida, Shigeaki Higashiyama, Joji Kawabe, Kohei Kotani, Hidemi Kawajiri, Yasuo Imanishi, Naoyoshi Onoda and Susumu Shiomi
    Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 474;
SNMMI

© 2025 SNMMI

Powered by HighWire